Detection of 16 p deletions by FISH in patients with inv(16) or t(16;16) and acute myeloid leukemia (AML)

Leukemia

Volumn 11, Issue 7, 1997, Pages 964-970

  Martinet, D ^a   Muhlematter D ^a   Leeman, M ^a   Parlier, V ^a   Hess, U ^b   Gmur J ^c   Jotterand, M ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b KANTONSSPITAL   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

16 p deletions; Acute myeloid leukemia; FISH; Inv(16)(p13q22); Prognosis; t(16; 16)(p13; q22)

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CENTROMERE; CHROMOSOME 16P; CHROMOSOME INVERSION; CHROMOSOME MOSAICISM; CHROMOSOME TRANSLOCATION 16; CLINICAL ARTICLE; COSMID; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; INTERSTITIAL CHROMOSOME DELETION; MALE; METAPHASE CHROMOSOME; PRIORITY JOURNAL;

EID: 0030825379     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400681     Document Type: Article

References (30)

1. Arthur DC, Bloomfield CD. Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: a new association. Blood 1983; 61: 994-998.
2. Arthur DC, Bloomfield CD. Correspondence. Blood 1983; 62: 931.
3. Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. New Engl J Med 1983; 309: 630-636.
4. Bitter MA, Le Beau MM, Larson RA, Rosner MC, Golomb HM, Rowley JD, Vardiman JW. A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22). Am J Clin Pathol 1984; 81: 733-741.
5. Hogge DE, Misawa S, Parsa NZ, Pollak A, Testa JR. Abnormalities of chromosome 16 in association with acute myelomonocytic leukemia and dysplastic bone marrow eosinophils. J Clin Oncol 1984; 2: 550-557.
6. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
7. Mitelman F. Catalog of Chromosome Aberrations in Cancer. Wiley-Liss: New York, 1994.
8. Liu PP, Hajra A, Wijmenga C, Collins FS. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995; 85: 2289-2302.
9. Larson RA, Williams SF, Le Beau MM, Bitter MA, Vardiman JW, Rowley JD. Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood 1986; 68: 1242-1249.
10. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR. Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 1989; 73: 263-270.
11. Plantier I, Lai JL, Wattel E, Bauters F, Fenaux P. Inv(16) may be one of the only 'favorable' factors in acute myeloid leukemia: a report on 19 cases with prolonged follow-up. Leukemia Res 1994; 18: 885-888.
12. Burnett AK. Karyotypically defined risk groups in acute myeloid leukaemia. Leukemia Res 1994; 18: 889-890.
13. Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E. Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16. Leukemia 1995; 9: 965-971.
14. Liu P, Tarlé SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041-1044.
15. Dauwerse JG, Wessels JW, Giles RH, Wiegant J, van der Reijden BA, Fugazza G, Jumelet EA, Smit E, Baas F, Raap AK, Hagemeijer A, Beverstock GC, Van Ommen GJ, Breuning MH. Cloning the breakpoint cluster region of the inv(16) in acute nonlymphocytic leukemia M4Eo. Hum Mol Genet 1993; 2: 1527-1534.
16. Kuss BJ, Deeley RG, Cole SP, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Lane SA, Nancarrow JK, Whitmore SA, Callen DF. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet 1994; 343: 1531-1534.
17. Kuss BJ, Deeley RG, Cole SP, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Callen DF. The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias. Leuk Lymphoma 1996; 20: 357-364.
18. Marlton P, Claxton DF, Liu P, Estey EH, Beran M, Le Beau M, Testa JR, Collins FS, Rowley JD, Siciliano MJ. Molecular characterization of 16 p deletions associated with inversion 16 defines the critical fusion for leukemogenesis. Blood 1995; 85: 772-779.
19. Van der Reijden BA, Lombardo M, Dauwerse HG, Giles RH, Mühlematter D, Jotterand Bellomo M, Wessels HW, Beverstock GC, Van Ommen GJ, Hagemeijer A, Breuning MH. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. Blood 1995; 86: 277-282.
20. Van der Reijden BA, Martinet D, Dauwerse JG, Giles RH, Wessels JW, Beverstock GC, Smit B, Mühlematter D, Jotterand Bellomo M, Gabert J, Lafage-Pochitaloff M, Reiffers J, Bilhou-Nabera C, Van Ommen GJ, Hagemeijer A, Breuning MH. Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia. Leukemia 1996; 10: 1459-1462.
21. Castagné C, Mühlematter D, van Melle G, Gachoud V, Jotterand Bellomo M. Effect of conditioned media, nutritive elements and mitotic synchronization on the accuracy of the cytogenetic analysis in acute nonlymphocytic leukemia patients presenting inv(16)/t(16;16) or t(15;17). Cancer Genet Cytogenet (in press).
22. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the acute leukaemias: French-American-British (FAB) Co-operative Group. Br J Haematol 1976; 33: 451-458.
23. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
24. Second MIC Cooperative Study Group. Morphologic, immunologie and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Br J Haematol 1988; 68: 487-494.
25. Jotterand Bellomo M, Parlier V, Schmidt PM, Beris P. Cytogenetic analysis of 54 cases of myelodysplastic syndrome. Cancer Genet Cytogenet 1990; 46: 157-172.
26. Jotterand Bellomo M, Parlier V, Mühlematter D, Grob JP, Beris P. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome. Cancer Genet Cytogenet 1992; 59: 138-160.
27. Moyzis RK, Albright KL, Bartholdi MF, Cram LS, Deaven LL, Hildebrand CE, Joste NE, Longmire JL, Meyne J, Schwarzacher-Robinson T. Human chromosome-specific repetitive DNA sequences: novel markers for genetic analysis. Chromosoma 1987; 95: 375-386.
28. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad SCi USA 1986; 83: 2934-2938.
29. Dauwerse JG, Wiegant J, Raap AK, Breuning MH, van Ommen GJ. Multiple colors by fluoresence in situ hybridization using radiolabelled DNA probes create a molecular karyotype. Hum Mol Genet 1992; 1: 593-598.
30. Zöchbauer S, Haas OA, Schwarzinger I, Lechner K, Pirker R. Multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16 of FAB M4Eo subtype. Lancet 1994; 344: 894.